Jayjun Co Ltd (025620.KS) stock: key figures, P/E, revenue and dividend
Consumer Staples · Personal Care Products · South Korea · ISIN KR7025620006
Jayjun Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 15.68 bn KRW | 7.31 bn KRW |
| Gross profit | 7.35 bn KRW | 2.06 bn KRW |
| Operating income | -4.85 bn KRW | -7.10 bn KRW |
| EBIT | -8.16 bn KRW | 2.45 bn KRW |
| Net income | -9.49 bn KRW | 1.37 bn KRW |
| Diluted EPS – continuing operations | -2,121.68 KRW | 75.13 KRW |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Jayjun Co Ltd
Cha AI Healthcare Co., Ltd., together with its subsidiaries, manufactures and distributes cosmetic products in South Korea. The company offers facial care products, including masks/packs, skin/toner/mist, pads/patches, ampoules/serums/essence, lotion/emulsion, creams/gels, cleansing/peeling, sun care, and beauty accessories products; skin cells/texture, moisture/moisturizing, whitening/brightening, and sensitive/calm care products; nutritional/elasticity/anti-aging care products; and UV protection care products. The company was formerly known as Jayjun Cosmetic Co., Ltd. and changed its name to Cha AI Healthcare Co., Ltd. in December 2025. Cha AI Healthcare Co., Ltd. was founded in 1972 and is headquartered in Seoul, South Korea.
More stocks
- Kec Corporation (092220.KS)
- Alliance Aviation Services Ltd (AQZ.AX)
- Mindax Ltd (MDX.AX)
- Norse Atlantic ASA (NORSE.OL)
- PT Buana Artha Anugerah Tbk (STAR.JK)
- Vaxcell-Bio Therapeutics Co. Ltd (323990.KQ)
- Genii Ideas Co., Ltd. (7631.TW)
- Shareholder Value Beteiligungen AG (SVE.DE)
- Aero Win Technology Corp (8222.TW)
- Gentian Diagnostics AS (GENT.OL)
- Li-S Energy Ltd (LIS.AX)
- West Vault Mining (WVM.V)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.